buspirone has been researched along with Astrocytoma in 1 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
Astrocytoma: Neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. Fibrillary astrocytomas are the most common type and may be classified in order of increasing malignancy (grades I through IV). In the first two decades of life, astrocytomas tend to originate in the cerebellar hemispheres; in adults, they most frequently arise in the cerebrum and frequently undergo malignant transformation. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2013-7; Holland et al., Cancer Medicine, 3d ed, p1082)
| Excerpt | Relevance | Reference |
|---|---|---|
| " This observation encouraged a treatment of severe apneusis with buspirone, an agonist for 5-HT1A receptors, in a child after neurosurgery for an astrocytoma in the pons and medulla oblongata." | 3.69 | Treatment of apneustic respiratory disturbance with a serotonin-receptor agonist. ( Behnke, J; Bischoff, AM; Christen, HJ; Hanefeld, F; Lalley, P; Richter, DW; Wilken, B, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wilken, B | 1 |
| Lalley, P | 1 |
| Bischoff, AM | 1 |
| Christen, HJ | 1 |
| Behnke, J | 1 |
| Hanefeld, F | 1 |
| Richter, DW | 1 |
1 other study available for buspirone and Astrocytoma
| Article | Year |
|---|---|
Treatment of apneustic respiratory disturbance with a serotonin-receptor agonist.
Topics: Animals; Astrocytoma; Brain Neoplasms; Brain Stem; Buspirone; Cats; Child, Preschool; Female; Humans | 1997 |